Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Etoposide × 90 days × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 18 Lymphoma, Large B-Cell, Diffuse 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Medulloblastoma 7 Lung Neoplasms 7 Burkitt Lymphoma 7 Lymphoma 6 Leukemia, Myeloid, Acute 6 Sarcoma, Ewing 5 Recurrence 5 Brain Neoplasms 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Hodgkin Disease 4 Ependymoma 4 Carcinoma, Non-Small-Cell Lung 4 Neuroblastoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell 3 Glioblastoma 3 Wilms Tumor 2 Teratoma 2 Sarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroendocrine Tumors 2 Neoplasms, Germ Cell and Embryonal 2 Leukemia 2 Glioma 2

Interventions

Cyclophosphamide 5 fludarabine 4 Dexamethasone 4 blinatumomab 3 Lenalidomide 3 pembrolizumab 2 fludarabine phosphate 2 Cytarabine 2 venetoclax 1 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 obinutuzumab 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 daratumumab 1 abemaciclib 1 Vincristine 1 Transplantation 1 Radiotherapy 1 Neoadjuvant Therapy 1 Monatide (IMS 3015) 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡